P38 MAP Kinase links CAR activation and inactivation in the nucleus via phosphorylation at threonine 38

Takeshi Hori, Rick Moore, Masahiko Negishi

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Nuclear receptor constitutive androstane receptor (CAR, NR1I3), which regulates hepatic drug and energy metabolisms as well as cell growth and death, is sequestered in the cytoplasm as its inactive form phosphorylated at threonine 38. CAR activators elicit dephosphorylation, and nonphosphorylated CAR translocates into the nucleus to activate its target genes. CAR was previously found to require p38 mitogen-Activated protein kinase (MAPK) to transactivate the cytochrome P450 2B (CYP2B) genes. Herewe have demonstrated that p38 MAPK forms a complex with CAR, enables it to bind to the response sequence, phenobarbital-responsive enhancer module (PBREM), within the CYP2B promoter, and thus recruits RNA polymerase II to activate transcription. Subsequently, p38 MAPK elicited rephosphorylation of threonine 38 to inactivate CAR and exclude it from the nucleus. Thus, nuclear p38MAPK exerted dual regulation by sequentially activating and inactivating CAR-mediated transcription through phosphorylation of threonine 38.

Original languageEnglish
Pages (from-to)871-876
Number of pages6
JournalDrug Metabolism and Disposition
Volume44
Issue number6
DOIs
Publication statusPublished - 2016
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'P38 MAP Kinase links CAR activation and inactivation in the nucleus via phosphorylation at threonine 38'. Together they form a unique fingerprint.

Cite this